BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18708761)

  • 21. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
    Wang OH; Azizian N; Guo M; Capello M; Deng D; Zang F; Fry J; Katz MH; Fleming JB; Lee JE; Wolff RA; Hanash S; Wang H; Maitra A
    PLoS One; 2016; 11(3):e0152300. PubMed ID: 27023625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
    Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.
    Nakata K; Ohuchida K; Nagai E; Hayashi A; Miyasaka Y; Kayashima T; Yu J; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
    Neoplasia; 2009 Jul; 11(7):712-9. PubMed ID: 19568416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological and prognostic significance of MUC13 and AGR2 expression in intraductal papillary mucinous neoplasms of the pancreas.
    Mito K; Saito M; Morita K; Maetani I; Sata N; Mieno M; Fukushima N
    Pancreatology; 2018 Jun; 18(4):407-412. PubMed ID: 29650332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
    Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
    Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
    Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
    Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
    Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.
    Bloomston M; Frankel WL; Petrocca F; Volinia S; Alder H; Hagan JP; Liu CG; Bhatt D; Taccioli C; Croce CM
    JAMA; 2007 May; 297(17):1901-8. PubMed ID: 17473300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor.
    Chen Y; Zhu H; Wang Y; Song Y; Zhang P; Wang Z; Gao J; Li Z; Du Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818824314. PubMed ID: 30803373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells.
    Erkan M; Weis N; Pan Z; Schwager C; Samkharadze T; Jiang X; Wirkner U; Giese NA; Ansorge W; Debus J; Huber PE; Friess H; Abdollahi A; Kleeff J
    Mol Cancer; 2010 Apr; 9():88. PubMed ID: 20416094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Phosphorylation Status of AKT/mTOR Signal in DESI2-Reduced Pancreatic Ductal Adenocarcinoma.
    Shen CC; Cui XY; He Y; Kang YH; Yi C; Yang JL; Gou LT
    Pathol Oncol Res; 2015 Apr; 21(2):267-72. PubMed ID: 25079376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
    Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
    Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
    Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of MUC13 in pancreatic ductal adenocarcinoma.
    Khan S; Zafar N; Khan SS; Setua S; Behrman SW; Stiles ZE; Yallapu MM; Sahay P; Ghimire H; Ise T; Nagata S; Wang L; Wan JY; Pradhan P; Jaggi M; Chauhan SC
    HPB (Oxford); 2018 Jun; 20(6):563-572. PubMed ID: 29352660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.